Male docs receive vast majority of payments from drug companies

| October 08, 2014 | Health Exec | Economics

More than 90 percent of the 300 doctors who received money from drug companies in exchange for speaking and consulting are men, reports The New York Times.

Meanwhile, men only account for 68 percent of active physicians in the U.S., according to the article.

This insight was gleaned from an analysis of data from the Centers for Medicare & Medicaid’s newly launched Open Payments database.

Around the web

Cardiovascular Business

Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.

AI in Healthcare

A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business

FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Male docs receive vast majority of payments from drug companies

Related Content

Around the web